Wedge Capital Management L L P Catalyst Pharmaceuticals, Inc. Transaction History

Wedge Capital Management L L P

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 11, 2023	BUY	$14.34 - $21.05 $16,849 - $24,733	1,175 Added 8.51%	14,978 $248,000
Q4 2022 Jan 17, 2023	BUY	$12.25 - $19.5 $46,341 - $73,768	3,783 Added 37.75%	13,803 $257,000
Q3 2022 Oct 13, 2022	SELL	$7.06 - $15.52 $47,273 - $103,921	-6,696 Reduced 40.06%	10,020 $129,000
Q2 2022 Jul 11, 2022	BUY	$6.23 - $8.57 $5,307 - $7,301	852 Added 5.37%	16,716 $117,000
Q1 2022 Apr 12, 2022	SELL	$5.31 - $8.31 $28,520 - $44,633	-5,371 Reduced 25.29%	15,864 $132,000
Q4 2021 Jan 24, 2022	SELL	$5.21 - $7.45 $12,217 - $17,470	-2,345 Reduced 9.94%	21,235 $144,000
Q3 2021 Oct 14, 2021	BUY	$4.85 - $6.04 $29,652 - $36,928	6,114 Added 35.01%	23,580 $125,000
Q2 2021 Jul 14, 2021	SELL	$4.29 - $6.05 $45,032 - $63,506	-10,497 Reduced 37.54%	17,466 $100,000
Q1 2021 Apr 12, 2021	SELL	$3.45 - $4.69 $555,356 - $754,963	-160,973 Reduced 85.2%	27,963 $129,000
Q4 2020 Jan 08, 2021	BUY	$2.97 - $3.83 $192,262 - $247,935	64,735 Added 52.12%	188,936 $631,000
Q3 2020 Oct 08, 2020	SELL	$2.97 - $5.08 $7,344 - $12,562	-2,473 Reduced 1.95%	124,201 $369,000
Q2 2020 Jul 10, 2020	BUY	$3.48 - $5.05 $440,825 - $639,703	126,674 New	126,674 $585,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.